Full Text View
Tabular View
No Study Results Posted
Related Studies
Primary UVB-311nm and Adalimumab in Psoriasis Patients
This study is currently recruiting participants.
Study NCT00638261   Information provided by Medical University of Graz
First Received: March 12, 2008   Last Updated: September 29, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
UVB-311nm
Additional drug interventions recognized in this trial
Adalimumab
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Medical University of Graz


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services